Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Robert, Wenham"'
Publikováno v:
Gynecologic Oncology Reports, Vol 36, Iss , Pp 100754- (2021)
Stage IIIC is the most common stage of locally advanced sub-stage of endometrial cancer, nevertheless, the optimal management for these patients remains controversial. Adjuvant chemotherapy alone more effectively suppressed distant metastases but res
Externí odkaz:
https://doaj.org/article/4ce00757bcef4ffe83de019d047c377b
Publikováno v:
Journal of Gynecologic Surgery. 39:49-52
Autor:
Maximilian Strobl, Alexandra L. Martin, Jeffrey West, Jill Gallaher, Mark Robertson-Tessi, Robert Gatenby, Robert Wenham, Philip Maini, Mehdi Damaghi, Alexander Anderson
Publikováno v:
bioRxiv
Toxicity and emerging drug resistance are important challenges in PARP inhibitor (PARPi) treatment of ovarian cancer. Recent research has shown that evolutionary-inspired treatment algorithms which adapt treatment to the tumor’s treatment response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d68267af23860d6915841b0caa12f1
https://europepmc.org/articles/PMC10055330/
https://europepmc.org/articles/PMC10055330/
Autor:
Robert Wenham, Marco Davila, Daniel Abate-Daga, Melissa McGettigan, Xuefeng Wang, Theresa Boyle, Pamela Garzone, Amit Kumar, Jose Conejo-Garcia
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Eugenia Girda, Emese Zsiros, John Nakayama, Sarah Whelan, Srinand Nandakumar, Seema Rogers, Beverly Benson, Michael Lotze, Robert Brown, Robert Wenham
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Robert Wenham, Sharad Ghamande, Vicky Makker, June Hou, Linda Duska, Daniela Matei, Manali Bhave, Rachael Scott, Natalyn Hawk, Tingting Song, Deborah K Armstrong
Publikováno v:
Ovarian cancer.
Autor:
Robert Wenham, Sharad Ghamande, Vicky Makker, June Hou, Linda Duska, Daniela Matei, Manali Bhave, Rachael Scott, Natalyn Hawk, Tingting Song, Deborah K. Armstrong
Publikováno v:
Cancer Research. 83:CT056-CT056
Background: MORAb-202 (farletuzumab ecteribulin) is an antibody-drug conjugate (ADC) comprised of the humanized antifolate receptor-alpha (FRα) monoclonal antibody, farletuzumab, and the cytotoxic microtubule inhibitor, eribulin, conjugated by a cat
Autor:
John K, Chan, Chunqiao, Tian, Joshua P, Kesterson, Bradley J, Monk, Daniel S, Kapp, Brittany, Davidson, Sharon, Robertson, Larry J, Copeland, Joan L, Walker, Robert, Wenham, Yovanni, Casablanca, Nick M, Spirtos, Krishnansu S, Tewari, Jeffery G, Bell
Publikováno v:
Obstetrics and gynecology. 139(6)
Autor:
Sarah Adams, Carolyn Muller, David O’Malley, Kari Ring, Robert Wenham, Karen Finkelstein, Teresa Rutledge, Elizabeth Lokich, Xavier Paliard, Olivier Rixe, Ichiko Kinjyo, Steven Eberhardt, Ji-Hyun Lee, Phyllis Gimotty
Publikováno v:
Gynecologic Oncology. 166:S60-S61
Publikováno v:
Gynecologic Oncology. 164:10-11